date/time interval
- September 14, 2023 - August 31, 2028
Targeting MALT1 to Enhance Anti-Lymphoma Immunity and Response to Immunotherapy
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R01 CA282889-01
Affiliation
contributor
- Melnick, Ari M. Co-Principal Investigator 2023 - 2028
- Zappasodi, Roberta Principal Investigator 2023 - 2028